Skip to main navigation
Skip to main content
Skip to page footer
Back
MX Healthcare GmbH
Vara develops an AI-powered software platform for breast cancer screening that supports screening radiologists in interpreting mammography results and reduces the human subjectivity associated with diagnoses. As the first company of the Merantix venture studio, the deep learning technology was developed together with screening radiologists in Germany and is backed by extensive clinical evidence. The CE-certified solution aims to make high-quality breast cancer screening more accessible and measurable worldwide.
